NCT00230594View on ClinicalTrials.gov

Desmopressin Response in the Young

PHASE3CompletedINTERVENTIONAL
Enrollment

132

Participants

Timeline

Start Date

July 31, 2004

Primary Completion Date

January 31, 2006

Study Completion Date

February 28, 2006

Conditions
Primary Nocturnal Enuresis
Interventions
DRUG

desmopressin

desmopressin 120 mcg melt tablet; 120 mcg, 240 mcg or 360 mcg administered once daily before bedtime

DRUG

placebo

placebo melt tablet; 1 to 3 placebo melt tablets administered once daily before bedtime

Trial Locations (9)

B3K 6R8

IWK Health Centre, Halifax

L4M 7G1

The Male Health Centres, Barrie

N3C 1Z3

Cambridge Family Medical Centre, Cambridge

Unknown

Private Clinic, London

L6B 1A1

Quest Clinical Trials Inc., Markham

P1B 4Z2

Private Clinic, North Bay

L6H 3P1

The Male Health Centres, Oakville

L3T 4X1

Markham Place Med Centre, Thornhill

L1N 8M7

The Kids Clinic, Whitby

Sponsors
All Listed Sponsors
lead

Ferring Pharmaceuticals

INDUSTRY

NCT00230594 - Desmopressin Response in the Young | Biotech Hunter | Biotech Hunter